NewGenIvf (NIVF) EBITDA (2024 - 2025)
NewGenIvf (NIVF) reported EBITDA of -$7.6 million for Q4 2025, down 20180.52% year-over-year from N/an in Q4 2024, and down 146.19% quarter-over-quarter from $16.4 million in Q3 2025.
NewGenIvf (NIVF) EBITDA (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has 2 years of EBITDA data on file, last reported at -$7.6 million in Q4 2025.
- EBITDA for Q4 2025 came in at -$7.6 million, down 20180.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.6 million (changed N/A YoY), and the FY2025 annual result was $9.5 million, up 2252.71% from the prior year.
- EBITDA eased to -$7.6 million in Q4 2025 per NIVF's latest filing, from $16.4 million in the prior quarter.
- Over five years, EBITDA peaked at $16.4 million in Q3 2025 and troughed at -$7.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -566.00 Mn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 1.30 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 481.89 Mn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 59.70 Mn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 124.85 Mn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 502.86 Mn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 1.13 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 98.88 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 120.04 Mn |
| 10 | NewGenIvf | - | - | 524,025.00 | -7.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.57 Mn |
| Sep 30, 2025 | 16.39 Mn |
| Dec 31, 2024 | -37,328.00 |
| Sep 30, 2024 | -208,254.00 |